Literature DB >> 31287999

Corticosteroids for Community-Acquired Pneumonia: Overstated Benefits and Understated Risks.

Grant Waterer1, Mark L Metersky2.   

Abstract

Entities:  

Keywords:  community-acquired pneumonia; corticosteroids

Mesh：

Substances：

Year:  2019        PMID： 31287999      PMCID： PMC6904851          DOI： 10.1016/j.chest.2019.06.017

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  40 in total

1.  In-Hospital Deaths Among Adults With Community-Acquired Pneumonia.

Authors:  Grant W Waterer; Wesley H Self; D Mark Courtney; Carlos G Grijalva; Robert A Balk; Timothy D Girard; Sherene S Fakhran; Christopher Trabue; Paul McNabb; Evan J Anderson; Derek J Williams; Anna M Bramley; Seema Jain; Kathryn M Edwards; Richard G Wunderink
Journal:  Chest       Date:  2018-05-30       Impact factor: 9.410

2.  Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.

Authors:  Antoni Torres; Oriol Sibila; Miquel Ferrer; Eva Polverino; Rosario Menendez; Josep Mensa; Albert Gabarrús; Jacobo Sellarés; Marcos I Restrepo; Antonio Anzueto; Michael S Niederman; Carles Agustí
Journal:  JAMA       Date:  2015-02-17       Impact factor: 56.272

3.  Dexamethasone in adults with bacterial meningitis.

Authors:  Jan de Gans; Diederik van de Beek
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

Review 4.  Pneumonia as a cardiovascular disease.

Authors:  Marcos I Restrepo; Luis F Reyes
Journal:  Respirology       Date:  2018-01-11       Impact factor: 6.424

5.  Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.

Authors:  Claudine Angela Blum; Nicole Nigro; Matthias Briel; Philipp Schuetz; Elke Ullmer; Isabelle Suter-Widmer; Bettina Winzeler; Roland Bingisser; Hanno Elsaesser; Daniel Drozdov; Birsen Arici; Sandrine Andrea Urwyler; Julie Refardt; Philip Tarr; Sebastian Wirz; Robert Thomann; Christine Baumgartner; Hervé Duplain; Dieter Burki; Werner Zimmerli; Nicolas Rodondi; Beat Mueller; Mirjam Christ-Crain
Journal:  Lancet       Date:  2015-01-19       Impact factor: 79.321

6.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

Authors:  G U Meduri; A S Headley; E Golden; S J Carson; R A Umberger; T Kelso; E A Tolley
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

7.  Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.

Authors:  Silvia Fernández-Serrano; Jordi Dorca; Carolina Garcia-Vidal; Núria Fernández-Sabé; Jordi Carratalà; Ana Fernández-Agüera; Mercè Corominas; Susana Padrones; Francesc Gudiol; Frederic Manresa
Journal:  Crit Care       Date:  2011-03-15       Impact factor: 9.097

Review 8.  Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update.

Authors:  Nobuyuki Horita; Tatsuya Otsuka; Shusaku Haranaga; Ho Namkoong; Makoto Miki; Naoyuki Miyashita; Futoshi Higa; Hiroshi Takahashi; Masahiro Yoshida; Shigeru Kohno; Takeshi Kaneko
Journal:  Sci Rep       Date:  2015-09-16       Impact factor: 4.379

9.  Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.

Authors:  Akbar K Waljee; Mary A M Rogers; Paul Lin; Amit G Singal; Joshua D Stein; Rory M Marks; John Z Ayanian; Brahmajee K Nallamothu
Journal:  BMJ       Date:  2017-04-12

10.  Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Authors:  Gerard Moreno; Alejandro Rodríguez; Luis F Reyes; Josep Gomez; Jordi Sole-Violan; Emili Díaz; María Bodí; Sandra Trefler; Juan Guardiola; Juan C Yébenes; Alex Soriano; José Garnacho-Montero; Lorenzo Socias; María Del Valle Ortíz; Eudald Correig; Judith Marín-Corral; Montserrat Vallverdú-Vidal; Marcos I Restrepo; Antoni Torres; Ignacio Martín-Loeches
Journal:  Intensive Care Med       Date:  2018-08-03       Impact factor: 17.440
View more
  4 in total

1.  How to improve research on management of critically ill patients: Lessons learned from negative randomised clinical trials in the intensive care unit.

Authors:  Jordi Rello; Lluis Blanch; Jean-Charles Preiser; Jan J De Waele
Journal:  Anaesth Crit Care Pain Med       Date:  2020-02-10       Impact factor: 4.132

Review 2.  Advances in community-acquired pneumonia.

Authors:  Barbara Jones; Grant Waterer
Journal:  Ther Adv Infect Dis       Date:  2020-11-06

Review 3.  Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

4.  2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.

Authors:  Mao Wang; Alex G Gauthier; Thomas P Kennedy; Haichao Wang; Uday Kiran Velagapudi; Tanaji T Talele; Mosi Lin; Jiaqi Wu; LeeAnne Daley; Xiaojing Yang; Vivek Patel; Sung Soo Mun; Charles R Ashby; Lin L Mantell
Journal:  Mol Med       Date:  2021-07-16       Impact factor: 6.354
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.